Shares of Zomedica ( NYSEMKT:ZOM ) surged 41% on Monday before pulling back after the market close.
Like many stocks that have caught the fancy of the increasingly popular WallStreetBets group on Reddit, Zomedica's share price has skyrocketed in recent weeks.
On Monday, Zomedica decided to take advantage of its torrid stock price to boost its cash reserves.
Zomedica is gearing up for the upcoming launch of its Truforma diagnostic platform for dogs and cats, which is slated for March 30.
Management is targeting a global pet diagnostics market that's projected to grow to $2.8 billion by 2024.
Zomedica said that it will use the cash from its stock offering to fund the development of Truforma, as well as make milestone payments to its technology partners.
- ZOM Stock Price Increases Over 45%: Why It HappenedPulse 2.0
- Best Penny Stocks For Your February 2021 Watch List? 5 Names To KnowPenny Stocks
- ZOM Stock: Retail Investors Send Zomedica FlyingCNA Finance
- Zomedica (ZOM) Resumes The Uptrend: Will it Hit $5?Own Snap
- Zomedica [ZOM] Announces Increase In Size Of Previously Announced Bought Deal Offering of Common SharesMZP News
- Zomedica Corp. [ZOM] is 728.27% higher this YTD. Is it still time to buy?The DBT News
- Looking At Zomedica's Potential Amid Recent Run-UpSeeking Alpha
- Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 MillionGlobeNewswire
- Zomedica Pharmaceuticals (ZOM) Announces $25 Million Bought Deal Offering of Common SharesStreetInsider.com
